Double‐bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS‐CoV‐2
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.17010
Abstract: ABSTRACT SARS‐CoV‐2, affecting predominantly elderlies, was recognized as a global pandemic in March 11th, 2020; clinical signs and laboratory alterations are similar to previous coronavirus epidemics with lymphocytopenia and neutrophilia observed in severe cases. read more here.
Keywords: double bright; cell adoptive; cd56bright cd16bright; bright cd56bright ... See more keywords